Guardian Pharmacy Services, Inc. (GRDN) is a publicly traded Healthcare sector company. As of May 21, 2026, GRDN trades at $37.63 with a market cap of $2.27B and a P/E ratio of 0.00. GRDN moved +3.53% today. Year to date, GRDN is +20.69%; over the trailing twelve months it is +42.00%. Its 52-week range spans $15.52 to $41.36. Analyst consensus is strong buy with an average price target of $43.00. Rallies surfaces GRDN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Guardian Pharmacy Q4 Revenue Up 18%, Adjusted EPS 37¢ Beats; 2026 EBITDA Raised: Guardian Pharmacy reported Q4 revenue of $397.6M, up 18% with 13% organic growth, and net income of $20.9M (33¢ EPS) alongside adjusted EPS of $0.37. It added $60M cash, exited at a $110M EBITDA run rate and raised 2026 EBITDA guidance despite a 90-bp margin drag.
| Metric | Value |
|---|---|
| Price | $37.63 |
| Market Cap | $2.27B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $41.36 |
| 52-Week Low | $15.52 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.46B |
| Net Income | $53.23M |
| Gross Margin | 20.93% |
4 analysts cover GRDN: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $43.00.